As the COVID-19 pandemic unfolded, India’s strategic response was marked by an innovative collaboration between academia and industry, backed by proactive governmental initiatives. Joint efforts between industry, academia, and government have been pivotal in advancing scientific research and accelerating the development of crucial healthcare products during the pandemic. The pandemic sparked a remarkable surge of cooperation between Indian academia and industry, supported by the government’s enhanced emphasis on research and development to effectively manage the outbreak. These collaborations were instrumental in bridging gaps, leveraging the unique capabilities of each sector, and mitigating weaknesses to swiftly achieve common goals. With a focus on complementing domain expertise, balancing resource strengths, and supplementing existing capacities, these partnerships varied in scope and formality, engaging different mixes of groups to drive innovation, scale-up, regulatory approvals and deployment. The pandemic-induced surge in cooperation between Indian academia and industry, supported by the government’s intensified focus on research and development, was key in developing vaccines, treatments, and diagnostics swiftly, showcasing a united effort to manage the crisis effectively and left behind varied lessons.